Protective effect of compound K against podocyte injury in chronic kidney disease by maintaining mitochondrial...

Area of Science:

• Nephrology
• Molecular Biology
• Pharmacology

Background:

• Chronic kidney disease (CKD) is a major global health concern, often progressing to end-stage renal disease (ESRD).
• Podocyte injury is a critical factor in glomerular dysfunction and CKD progression.
• Compound K (CK), a ginsenoside metabolite, shows potential for nephroprotection.

Purpose of the Study:

• To investigate the therapeutic potential of Compound K (CK) in a folic acid (FA)-induced mouse model of CKD.
• To elucidate the mechanisms underlying CK's nephroprotective effects on podocytes and mitochondria.

Main Methods:

• Induction of CKD in mice using folic acid (FA).
• Administration of Compound K (CK) to assess its effects on renal function and podocyte injury.
• Analysis of inter-podocyte junctions, podocyte motility, detachment, and apoptosis.
• Investigation of mitochondrial dynamics, including fission and mitophagy.
• Assessment of the Drp1-Bax dimer formation.

Main Results:

• CK treatment restored renal function and significantly mitigated podocyte injury in the CKD model.
• CK reinforced inter-podocyte junctions, reduced podocyte detachment, and prevented apoptosis.
• CK normalized mitochondrial homeostasis by reducing pathological fission and enhancing mitophagy.
• CK treatment appeared to disrupt the Drp1-Bax dimer, inhibiting mitochondrial apoptosis.

Conclusions:

• Compound K (CK) demonstrates potent nephroprotective effects against FA-induced CKD in mice.
• CK safeguards the glomerular filtration barrier by protecting podocytes and restoring mitochondrial function.
• CK represents a promising therapeutic candidate for managing progressive renal disease and CKD.